Exchange Traded Concepts’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Exchange Traded Concepts’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,160	Closed	-$94.4K	–	1441
2023 Q3	$94.4K	Buy	14,160 +58	+0.4%	+$482	﹤0.01%	917
2023 Q2	$128K	Buy	+14,102	New	+$124K	﹤0.01%	890

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Exchange Traded Concepts's PNT Position: Q4 2023 in Review

Exchange Traded Concepts sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 14,160 shares — an estimated $94.4K sold.

Exchange Traded Concepts first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $128K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Exchange Traded Concepts reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Exchange Traded Concepts sold 14,160 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $94.4K.
Exchange Traded Concepts first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
Exchange Traded Concepts's POINT Biopharma Global Inc. Common Stock position peaked at $128K in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Exchange Traded Concepts's 13F filing for Q4 2023, filed 5 Jan 2024.